Truveta welcomes Rod Hochman, MD, president and CEO of Providence, as new Truveta Board of Directors Chair
May 13, 2024 09:00 ET
|
Truveta
BELLEVUE, Wash., May 13, 2024 (GLOBE NEWSWIRE) -- Today Truveta, a growing collective of more than 30 health systems with a mission of Saving Lives with Data, welcomes Rod Hochman, MD, president and...
EQUASENS : Chiffre d’affaires T1 2024
May 07, 2024 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 7 mai 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires T1 2024 à 53,3 M€ La contribution des croissances externes équilibre l’effet de base du SégurLes Divisions...
Equasens: Q1 2024 revenue
May 07, 2024 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 7 May 2024 - 6:00 p.m. (CET) PRESS RELEASE Q1 2024 revenue: €53.3 million Contributions from new acquisitions offset the base effect from the Ségur digital healthcare investment...
EQUASENS : Résultats Annuels 2023
March 29, 2024 13:02 ET
|
EQUASENS
Villers-lès-Nancy, le 29 mars 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Résultats Annuels 2023 Résultats impactés par une surperformance fin 2022 et début 2023 liée au déploiement des versions SEGUR...
Equasens: 2023 Annual Results
March 29, 2024 13:02 ET
|
EQUASENS
Villers-lès-Nancy, 29 March 2024 - 6:00 p.m. (CET) PRESS RELEASE 2023 Annual Results Annual results impacted by the overperformance at the end of 2022 and early 2023 driven by solutions introduced...
EQUASENS : Chiffre d’affaires 2023 : +2,6 % à 219,7 M€
February 06, 2024 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 6 février 2024 - 18h00 (CET) COMMUNIQUE DE PRESSE Chiffre d’affaires 2023 : +2,6 % à 219,7 M€ L’activité 2023 du Groupe Equasens progresse, malgré un effet de base...
Equasens: 2023 revenue: €219.7m, +2.6%
February 06, 2024 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 6 February 2024 - 6:00 p.m. (CET) PRESS RELEASE 2023 revenue: €219.7m, +2.6% Equasens Group reported growth in annual revenue, despite an unfavourable comparison base from the...
EQUASENS : Prise de participation majoritaire dans DIGIPHARMACIE
January 02, 2024 12:00 ET
|
EQUASENS
Villers-lès-Nancy, le 2 janvier 2024 – 18:00 (CET) COMMUNIQUE DE PRESSE Prise de participation majoritaire dans DIGIPHARMACIE, Expert en digitalisation et gestion des factures en pharmacie Avec...
Equasens: Acquisition of a majority stake in DIGIPHARMACIE
January 02, 2024 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 2 January 2024 - 6:00 p.m. (CET) PRESS RELEASE Acquisition of a majority stake in DIGIPHARMACIE, An expert in digital and invoice management solutions for pharmacies With this...
Equasens: Changes in the Equasens Group Executive Committee
December 27, 2023 12:00 ET
|
EQUASENS
Villers-lès-Nancy, 27 December 2023 - 6:00 p.m. (CET)PRESS RELEASE Changes in the Equasens Group Executive Committee Equasens Group, a leading healthcare software publisher (Euronext Paris™ -...